Kerrey J Robert's Form 4 filing
Tenet Healthcare CorpTHC · filed Mar 12, 2025
- Accession no.
- 0000950170-25-038213
- Filed
- Mar 12, 2025
- Trade date
- Mar 11, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $1.19M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kerrey J RobertCIK 0001179100 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | Common Stock | SSaleDisposed | −3,409 | $124.67F1 | −$425,000.03 | 33,494 | Direct | |
| Mar 11, 2025 | Common Stock | SSaleDisposed | −1,739 | $125.61F2 | −$218,435.79 | 31,755 | Direct | |
| Mar 11, 2025 | Common Stock | SSaleDisposed | −2,177 | $126.43F3 | −$275,238.11 | 29,578 | Direct | |
| Mar 11, 2025 | Common Stock | SSaleDisposed | −938 | $124.60F4 | −$116,874.8 | 28,640 | Direct | |
| Mar 11, 2025 | Common Stock | SSaleDisposed | −1,136 | $126.08F5 | −$143,226.88 | 27,504 | Direct | |
| Mar 11, 2025 | Common Stock | SSaleDisposed | −126 | $126.80F6 | −$15,976.8 | 27,378 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $124.15 to $125.09.
Referenced by the price of 1 transaction in Table I.
- F2
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $125.15 to $126.09.
Referenced by the price of 1 transaction in Table I.
- F3
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $126.18 to $126.92.
Referenced by the price of 1 transaction in Table I.
- F4
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $124.24 to $125.11.
Referenced by the price of 1 transaction in Table I.
- F5
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $125.52 to $126.45.
Referenced by the price of 1 transaction in Table I.
- F6
The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $126.79 to $126.85.
Referenced by the price of 1 transaction in Table I.